Lung cancer in females: Military cancer center experience in Jordan

Objective: to evaluate the clinical properties, pathological properties and the survival data for 80 lung cancer female patients who were managed in our center. Methods: this retrospective study included 80 female patients with lung cancer that were treated in The Military Cancer Center of the Jordanian Royal Medical services between January 2022 and January 2024, the patients pathological, clinical and survival data will be reviewed and analyzed. Results: group age was between 41 to 82 years (mean of 60.18 ± 11.72). 82.5% of patients were diagnosed with non-small cell lung cancer (NSCLC), 17.5% of patients had small cell lung cancer (SCLC), 30% of patients were smokers. Significant weight loss was observed in 40% of patients. Comorbidity was present in 43.75% of patients with hypertension being the most common one 36.25%. Adenocarcinoma was the most common histological subtype 56%. The one-year survival rate was 70% and the two-year survival rate was 37.5%. Conclusion: our study showed that advanced stage, weight loss, poor ECOG score and NSCLC subtype were a main prognostic factors in females with lung cancer in Jordan.